Document Preview
  • Full Text
  • Dissertation or Thesis

Oral Administration of Epigallocatechin-3-Gallate (EGCG) is a Potential Therapeutic for Cisplatin-Induced Hearing Loss

. 
 Southern Illinois University at Carbondale ProQuest Dissertations & Theses,  2017. 10637479.